Find information on thousands of medical conditions and prescription drugs.

Acute myelocytic leukemia

Acute myelogenous leukemia (AML), also known as acute myeloid leukemia, is a cancer of the myeloid line of blood cells. The median age of patients with AML is 70; it is rare among children. more...

Home
Diseases
A
Aagenaes syndrome
Aarskog Ose Pande syndrome
Aarskog syndrome
Aase Smith syndrome
Aase syndrome
ABCD syndrome
Abdallat Davis Farrage...
Abdominal aortic aneurysm
Abdominal cystic...
Abdominal defects
Ablutophobia
Absence of Gluteal muscle
Acalvaria
Acanthocheilonemiasis
Acanthocytosis
Acarophobia
Acatalasemia
Accessory pancreas
Achalasia
Achard syndrome
Achard-Thiers syndrome
Acheiropodia
Achondrogenesis
Achondrogenesis type 1A
Achondrogenesis type 1B
Achondroplasia
Achondroplastic dwarfism
Achromatopsia
Acid maltase deficiency
Ackerman syndrome
Acne
Acne rosacea
Acoustic neuroma
Acquired ichthyosis
Acquired syphilis
Acrofacial dysostosis,...
Acromegaly
Acrophobia
Acrospiroma
Actinomycosis
Activated protein C...
Acute febrile...
Acute intermittent porphyria
Acute lymphoblastic leukemia
Acute lymphocytic leukemia
Acute mountain sickness
Acute myelocytic leukemia
Acute myelogenous leukemia
Acute necrotizing...
Acute promyelocytic leukemia
Acute renal failure
Acute respiratory...
Acute tubular necrosis
Adams Nance syndrome
Adams-Oliver syndrome
Addison's disease
Adducted thumb syndrome...
Adenoid cystic carcinoma
Adenoma
Adenomyosis
Adenosine deaminase...
Adenosine monophosphate...
Adie syndrome
Adrenal incidentaloma
Adrenal insufficiency
Adrenocortical carcinoma
Adrenogenital syndrome
Adrenoleukodystrophy
Aerophobia
Agoraphobia
Agrizoophobia
Agyrophobia
Aicardi syndrome
Aichmophobia
AIDS
AIDS Dementia Complex
Ainhum
Albinism
Albright's hereditary...
Albuminurophobia
Alcaptonuria
Alcohol fetopathy
Alcoholic hepatitis
Alcoholic liver cirrhosis
Alektorophobia
Alexander disease
Alien hand syndrome
Alkaptonuria
Alliumphobia
Alopecia
Alopecia areata
Alopecia totalis
Alopecia universalis
Alpers disease
Alpha 1-antitrypsin...
Alpha-mannosidosis
Alport syndrome
Alternating hemiplegia
Alzheimer's disease
Amaurosis
Amblyopia
Ambras syndrome
Amelogenesis imperfecta
Amenorrhea
American trypanosomiasis
Amoebiasis
Amyloidosis
Amyotrophic lateral...
Anaphylaxis
Androgen insensitivity...
Anemia
Anemia, Diamond-Blackfan
Anemia, Pernicious
Anemia, Sideroblastic
Anemophobia
Anencephaly
Aneurysm
Aneurysm
Aneurysm of sinus of...
Angelman syndrome
Anguillulosis
Aniridia
Anisakiasis
Ankylosing spondylitis
Ankylostomiasis
Annular pancreas
Anorchidism
Anorexia nervosa
Anosmia
Anotia
Anthophobia
Anthrax disease
Antiphospholipid syndrome
Antisocial personality...
Antithrombin deficiency,...
Anton's syndrome
Aortic aneurysm
Aortic coarctation
Aortic dissection
Aortic valve stenosis
Apert syndrome
Aphthous stomatitis
Apiphobia
Aplastic anemia
Appendicitis
Apraxia
Arachnoiditis
Argininosuccinate...
Argininosuccinic aciduria
Argyria
Arnold-Chiari malformation
Arrhythmogenic right...
Arteriovenous malformation
Arteritis
Arthritis
Arthritis, Juvenile
Arthrogryposis
Arthrogryposis multiplex...
Asbestosis
Ascariasis
Aseptic meningitis
Asherman's syndrome
Aspartylglycosaminuria
Aspergillosis
Asphyxia neonatorum
Asthenia
Asthenia
Asthenophobia
Asthma
Astrocytoma
Ataxia telangiectasia
Atelectasis
Atelosteogenesis, type II
Atherosclerosis
Athetosis
Atopic Dermatitis
Atrial septal defect
Atrioventricular septal...
Atrophy
Attention Deficit...
Autoimmune hepatitis
Autoimmune...
Automysophobia
Autonomic dysfunction
Familial Alzheimer disease
Senescence
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Medicines

Myeloid leukemias are characterized as "acute" or "chronic" based on how quickly they progress if not treated. Chronic myelogenous leukemia (CML) is often without symptoms and can remain dormant for years before transforming into a blast crisis, which is markedly similar to AML.

Pathophysiology

Specific chromosomal abnormalities are seen in patients with some forms of AML. These chromosomal abnormalities tend to disrupt genes that encode for transcription factors needed for myeloid stem cells to differentiate into specific blood components. Without differentiation occurring, these myeloid precursor cells fill the bone marrow and spill out into the blood. The overpopulation of the bone marrow with myeloid precursors also results in supression of normal marrow stem cells, giving rise to the symptoms of anemia (lack of red blood cells), thrombocytopenia (lack of platelets), and neutropenia (lack of neutrophils).

Subtypes

World Health Organization (WHO) classification

The World Health Organization (WHO) classification of acute myeloid leukemia (AML) attempts to be more applicable and produce more meaningful prognostic information then the older French-American-British (FAB) criteria, described below.

The WHO criteria are:

  • AML with characteristic genetic abnormalities, which includes AML with translocations between chromosome 8 and 21 , inversions in chromosome 16 and acute promyelocytic leukemia (APL). Patients with AML in this category generally have a high rate of remission and a better prognosis compared to other types of AML.
  • AML with multilineage dysplasia. This category includes patients who have had prior myelodysplastic syndrome (MDS) or a myeloproliferative diseases (MPD) that transforms into AML. This category of AML occurs primarily in elderly patients
  • AML and MDS, therapy related. This category includes patients who have had prior chemotherapy and/or radiation and subsequently develop AML or MDS.
  • AML not otherwise categorized. Includes subtypes of AML that do not fall into the above categories.
  • Acute leukemias of ambiguous lineage. Acute leukemias of ambiguous lineage (also known as mixed phenotype acute leukemia) occur when the leukemic cells can not be classified as either myeloid or lymphoid cells or where both types of cells are present.

French-American-British (FAB) classification

The older French-American-British (FAB) classification system divided AML into 8 subtypes, M0 through to M7 based on the type of cell from which the leukemia developed and degree of maturity. This is done by examining the appearance of the malignant cells under light microscopy or cytogenetically by characterization of the underlying chromosomal abnormality. Each subtype is characterised by a particular pattern of chromosomal translocations and have varying prognoses and responses to therapy. Although the WHO classification is more useful, the FAB system is still in use.

Read more at Wikipedia.org


[List your site here Free!]


Leukemia stains
From Gale Encyclopedia of Medicine, 4/6/01 by Nancy J. Nordenson

Definition

Leukemia stains are laboratory tests done on bone marrow or blood samples to help diagnose specific types of leukemia.

Purpose

Leukemia stains are done to diagnose and classify leukemia. Blood contains red cells, several varieties of white cells, and platelets. Cancerous overproduction of any one type of cell produces one of many types of leukemia. A patient's specific type of leukemia must be classified in order to provide the best treatment and most accurate prognosis.

The type and maturity of the cells involved are identified by analyzing blood and bone marrow under a microscope. Often, however, the abnormality or immaturity of the cells make it difficult to identify the cell types with certainty. Special leukemia stains help to distinguish one cell type from another.

Description

Special stains are added to bone marrow or blood that has been smeared on a microscope slide. Cell types react differently to the chemicals in the stains.

If the patient has few white cells, a buffy coat smear is made. A tube of blood is spun in a centrifuge. Red cells fall, plasma rises, and white cells settle in a thin middle layer called the buffy coat. The smear is made from this layer.

Sudan black B stain

This stain distinguishes between acute lymphoblastic leukemia (cells stain positive) and acute myeloblastic leukemia (cells stain negative).

Periodic acid-Schiff stain (PAS)

The PAS stain is primarily used to identify erythroleukemia, a leukemia of immature red blood cells. These cells stain a bright fuchsia.

Terminal deoxynucleotidyl transferase stain (TdT)

The TdT stain differentiates between acute lymphoblastic leukemia (cells stain positive) and acute myelogenous leukemia (cells stain negative).

Leukocyte alkaline phosphatase (LAP)

The LAP stain is used to determine if an increase of cells is due to chronic myelogenous leukemia or a noncancerous reaction to an infection or similar conditions. Cells from a noncancerous reaction stain positive with many intense blue granules; cells from chronic myelogenous leukemia have few blue granules.

Tartrate-resistant acid phosphatase stain (TRAP)

The TRAP stain is primarily used to identify hairy cell leukemia cells. These cells stain with purple to dark red granules.

Myeloperoxidase stain

The myeloperoxidase stain distinguishes between the immature cells in acute myeloblastic leukemia (cells stain positive) and those in acute lymphoblastic leukemia (cells stain negative).

Leukocyte specific esterase

This stain identifies granulocytes, which show red granules.

Leukocyte nonspecific esterase

Nonspecific esterase stain identifies monocytes and immature platelets (megakaryocytes), which show positive black granules.

Preparation

Leukemia stains are done on smears of blood or bone marrow. To collect blood, a healthcare worker draws blood from a vein in the inner elbow region. Collection of the sample takes only a few minutes.

When bone marrow is needed, the person is given local anesthesia. Then the physician inserts a needle through the skin and into the bone--usually the breast bone or hip bone--and 0.5-2 mL of bone marrow is withdrawn. This procedure takes approximately 30 minutes.

Aftercare

Patients sometimes feel discomfort or bruising at the puncture site after blood collection. They may also become dizzy or faint. Pressure to the puncture site until the bleeding stops reduces bruising. Warm packs to the puncture site relieve discomfort.

Collection of bone marrow is done under a physician's supervision. The patient is asked to rest after the procedure and is watched for weakness and signs of bleeding.

Normal results

A normal blood or bone marrow smear shows no evidence of leukemic cells. The expected reaction of cells varies with the type of stain.

Abnormal results

Leukemia stain results that help diagnosis and classify leukemia are supported by the results of other laboratory tests and the person's clinical condition.

Key Terms

Bone marrow
The spongy tissue inside large bones where blood cells are formed.
Buffy coat
The thin layer of concentrated white blood cells that forms when a tube of blood is spun in a centrifuge.
Leukemia
Any of several cancers of the bone marrow characterized by the abnormal increase of a type of blood cell.
Leukemia stains
Special stains added to smears of blood or bone marrow, performed to diagnose and classify leukemia.

Further Reading

For Your Information

    Books

  • Fischbach, Francis. Manual of Laboratory and Diagnostic Tests. Philadelphia: Lippincott, 1996.

Gale Encyclopedia of Medicine. Gale Research, 1999.

Return to Acute myelocytic leukemia
Home Contact Resources Exchange Links ebay